Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medikaloka Hermina Tbk. (HEAL) vs Mandom Indonesia Tbk. (TCID) Price & Performance

Medikaloka Hermina Tbk.Trade
Mandom Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Medikaloka Hermina Tbk. vs Mandom Indonesia Tbk. — how do they compare? Medikaloka Hermina Tbk. trades at Rp890 (market cap 13.68T, 877.9K 24h volume), while Mandom Indonesia Tbk. trades at Rp2,740 (market cap 1.09T, 200 24h volume). The key difference: Medikaloka Hermina Tbk. is far larger — about 12.6× Mandom Indonesia Tbk.'s market cap, and Medikaloka Hermina Tbk. is more actively traded (877.9K versus 200). Which is the better fit depends on your goals.

HEALTCID
Market Cap
13.68T1.09T
Volume
877.9K200
Lot
8.78K2
Turnover
781.77M544K
Average Price
890.52,720
Value
781.77M544K
Indicative Equilibrium Price
895
Indicative Equilibrium Volume
201

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HEAL
View details
TCID
View details

About Medikaloka Hermina Tbk.

PT Medikaloka Hermina Tbk (“the Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.

Read more on HEAL

About Mandom Indonesia Tbk.

PT. Mandom Indonesia Tbk (the Company), formely PT Tancho Indonesia Tbk was incorporated under the framework of the Foreign Capital Investment law dated November 5, 1969.The Company’s Articles of Association have been amended several times, including change of par value from Rp. 1000 to Rp. 500,- and change in name to PT Tancho Indonesia Tbk. Then increase in the authorized share capital to Rp 312 billion and issued and paid up capital to Rp. 78 billion. At an Extraordinary General Meeting of Share Holders dated November 2000, it was resolved to change the company’s name to PT Mandom Indonesia Tbk.The company is located in Jakarta and factories are located in Jakarta and Industrial Estate MM2100, Cibitung, West Java. The Company commenced commercial production in April 16, 1971.

Read more on TCID